India accounts for more than a quarter of the global burden of tuberculosis (TB), and for this reason is often called the TB capital of the world. 1 In a recent report titled, India Health of Nation’s States, TB was listed as one of the top ten causes of death in the country. 2 In recent years, the rapid emergence of multidrug-resistant TB (MDR-TB) – which does not respond to at least two of the most commonly used TB treatments – has made the situation worse.
Johnson & Johnson India has announced a strategic partnership with the Government of Maharashtra to implement focused disease interventions that have the potential to significantly improve the health of people and strengthen health care in the state.
Thanks to their groundbreaking solutions for treating malnourished kids, saving mothers' lives and more, these big thinkers—all winners of Johnson & Johnson's GenH Challenge—are poised to reshape healthcare for future generations.